Skip to content
Trial Eligibility
Menu

Effectiveness of Aquamin® in Mitigating Halitosis

NCT05058638

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this study is to assess whether Aquamin®, a multi-mineral natural product from red marine algae, can help reduce halitosis when taken for 90 days.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Healthy
  • Halitosis

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
18 to 99 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of Michigan
Last updated on ClinicalTrials.gov
August 28, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Michigan · 1

  • University of Michigan School of Dentistry · Ann Arbor, MI

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.